Mainly because individuals that have the APOE e4 gene variant surface to possess a larger threat of serious problems, the FDA suggests staying tested with the gene variant before beginning treatment with lecanemab or donanemab. Immediately after currently being diagnosed with dementia, you'll need to consider quite a few information https://wesleyk319itd9.blogsuperapp.com/profile